论文部分内容阅读
目的 :观察扶正化痰合剂防治小儿哮喘的临床疗效。方法 :将 10 0例患儿随机分为扶正化痰合剂治疗组、酮替芬对照组各 5 0例 ,并观察治疗前后哮喘发作的次数及发作程度、血IgE、EOS的变化。结果 :在减少哮喘发作次数及减轻发作程度 ,降低血IgE及嗜酸性粒细胞水平等方面 ,治疗组均明显优于对照组 (P <0 0 5 )。结论 :扶正化痰合剂的临床疗效优于西药酮替芬 ;扶正化痰合剂可能是通过调节患儿血中IgE水平及嗜酸性粒细胞水平 ,从而改善患儿的病理变化 ,缓解哮喘发作。
Objective: To observe the clinical effects of “Fuzheng Huatan Mixture” on prevention and treatment of pediatric asthma. Methods: One hundred and ten cases of children were randomly divided into Fuzheng Huatan Mixture group and ketotifen control group with 50 cases each. The number of asthma attacks, the degree of attack, the changes of IgE and EOS in blood were observed before and after treatment. Results: The treatment group was significantly better than the control group (P <0.05) in reducing the number of asthma attacks, reducing the degree of seizures, lowering the blood IgE and eosinophil levels. Conclusion: The clinical curative effect of Fuzheng Huatan Mixture is superior to that of western medicine ketotifen. Fuzheng Huatan Mixture may improve the pathological changes in children and relieve the asthma attack by regulating IgE level and eosinophil level in children.